Product Browser

Last updated: 2016/12/4

Product Compare

Product Compare Cancel Click this icon to add products to compare list. Select up to 10 products.

Quick Order (Tutorial)

Input Catalog #,
place order here!
Catalog # :
  • Where to buy
  • Choose your location

A2ML1 293T Cell Transient Overexpression Lysate(Denatured)

  • Catalog # : H00144568-T01
  • Visit Frequency :
  • Countries :
  • Specification
  • Transfected Cell Line:
  • 293T
  • Plasmid:
  • pCMV-A2ML1 full-length
  • Host:
  • Human
  • Theoretical MW (kDa):
  • 17.49
  • Quality Control Testing:
  • Transient overexpression cell lysate was tested with Anti-A2ML1 antibody (H00144568-B01) by Western Blots.
    SDS-PAGE Gel
    QC Testing of H00144568-T01
    A2ML1 transfected lysate.
    Western Blot
    QC Testing of H00144568-T01
    Lane 1: A2ML1 transfected lysate ( 17.49 KDa)
    Lane 2: Non-transfected lysate.
  • Storage Buffer:
  • 1X Sample Buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 300 mM 2-mercaptoethanol, 0.01% Bromophenol blue)
  • Storage Instruction:
  • Store at -80°C. Aliquot to avoid repeated freezing and thawing.
  • Applications
  • Western Blot
  • Application Image
  • Western Blot
  • Gene Information
  • Gene Name:
  • A2ML1
  • Gene Alias:
  • CPAMD9,DKFZp686C1729,DKFZp686D2011,DKFZp686G1812,DKFZp686L1821,DKFZp686O1010,FLJ16045,FLJ25179,FLJ39129,FLJ41597,FLJ41598,FLJ41607
  • Gene Description:
  • alpha-2-macroglobulin-like 1
  • Gene Summary:
  • The alpha-macroglobulin (AM) superfamily of proteins contains both complement components and protease inhibitors, including A2M (MIM 103950) and A2ML1. AM proteins display a unique trap mechanism of inhibition, by which the AM inhibitor undergoes a major conformational change upon its cleavage by a protease, thus trapping the protease and blocking it from subsequent substrate binding (Galliano et al., 2006 [PubMed 16298998]).[supplied by OMIM
  • Other Designations:
  • C3 and PZP-like, alpha-2-macroglobulin domain containing 9,OTTHUMP00000158614
  • RSS
  • YouTube
  • Linkedin
  • Facebook